<<
>>

.. - . . . - . 1997; 2(1): 76-79. . . : /- . , .
. 2005; 14(5): 1-4. .. : . .... . . . ., 2004. .., ..

- . :   .

. , 2007. .., ..,

.. . , . 2000; 45(11): 29-30. .. . - 2004; 4: 6065. .., .. . : , 1998. .. . 2000; 3: 56-60. .. , , . , . 1995; 9(40): 47-56. .. - - : . . ... - . . ., 1992. .., .., .., .. . . - . . 2006; 8: 42-47. .., .. . Consilium Medicum 2007; 9(4). Amsden G.W. Anti-inflammatory effects of macrolides an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions? J.

Anti- microb. Chemother. 2005; 55: 10-21. Bacci P., Gross A., Vannucchi ./. ef al. Effects of miocamycin and erythromycin on polymorphonuclear cell function. J. Chemother. 1992; 5: 268-270. Bosnar M., Kelneric Z., Munic V. et al. Cellular Uptake and Efflux of Azithromycin, Erythromycin, Clarithromycin, Telithromy- cin, and Cethromycin. Antimicrob. Agents Chemother. 2005; 49: 2372-2377. Craig W.A., Gudmundson S. Postantibiotic effect. In: Antibiotics in Laboratory Medicine. Ed. by V. Loran. Baltimore, 1996: 403431. Culic O., Erakovic V., Cepelak I. et al.

Azithromycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjects. Eur. J. Pharmacol. 2002; 450: 277-289. Culic O., Erakovic V., Parnham M.J. Anti-inflammatory effects of macrolide antibiotics. Eur. J. Pharmacol. 2001; 429(1-3): 209-229. Culic ., Erakovic V., Langelot M. et al.

Mechanism of intracellular killing and modulation of abtibiotic susceptibility of Listeria monocytogenes in THP-1 macrophages activated by gamma interferon. Antimicrob. Agents Chemother. 1999; 43: 1242-1251. Culic O., Erakovic V., Langelof M. et al. Inhibitory effect of erythromycin on inter- lukin-8 production by alpha, 25-dihydroxy vitamin D3-stimulated THP-1 cells. Antimicrob. Agents Chemother. 1996; 40: 1548-1551. Daenas C., Hatziefthimiou A.A., Gourgou- lianis K.I., Molyvdas P.A. Azithromycin has a direct relaxant effect on precontracted airway smooth muscle. Eur. J. Pharmacol. 2006; 553:280-287. De Vecchi E., Nicola L., Zucchetti E., Drago

L. In vitro induction of resistance by tissue concentrations of azithromycin, clarithromycin, cefixime and amoxicillin/clavula- nate in clinical isolates of Streptococcus pyogenes. J. Chemother. 2006; 18: 379-388. Denis A., Agouridas C., Auger J. M. et al. Synthesis and antibacterial activity of HMR 3647, a new ketolide highly potent against erythromycin-resistant and susceptible pathogens. Bioorg. Med. Chem. Lett. 1999; 9: 3075-3080. Dugnani S., Demartini G., Triscari F., Fra- schini F.

Immunostimulation by clarithromycin in healthy volunteers and chronic bronchitis patients. J. Chemother. 1993; 5: 228-232. Feldman C., Anderson R., Theron A.J. et

al. Roxithromycin, clarithromycin, and azithromycin attenuate the injurious effects of bioactive phospholipids on human respiratory epithelium in vitro. Inflamation. 1997; 21: 655-665. Frank M.O., Sullivan G.W., Carper H.T., Mandell G.L. In vitro demonstration of transport and delivery of antibiotics by polymorphonuclear leukocytes. Antimicrob. Agents Chemother. 1992; 36: 25842588. Fuji T., Kadota J.-l., Morikawa T. etal. Inhibitory effect of erythromycin on interlukin-8 production by alpha, 25-dihydroxy vitamin D3-stimulated THP-1 cells. Antimicrob. Agents Chemother. 1996; 40: 1548-1551. Garcia /., Pascual A., Guzman M.C., Perea E.J. Effect of miocamycin and erythromycin on the activity of human neutrophils against Staphylococcus aureus. Enferm. Infec. Microbiol. Clin. 1991; 8: 459-463. Gladue R.P., Bright G.M., Isaacson R.E., Newborg M.F. In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. Antimicrob. Agents Chemother. 1989; 33: 277-282. Gorski N.P., Krzeski A. Medical management of chronic rhinosinusitis with macro- lides. Pol. Merkur. Lekarski. 2005; 19: 490493. Hammerschlag M.R., Sharma R. Use of ce-

thromycin, a new ketolide for treatment of community-acquired respiratory infections. Exp. Opin. Invest. Drugs 2008; 17: 387-400. Hori S., Sato J., Kawamura M. Macrolides increase endogenous glucocorticoid levels. In: The 36th Conference on Antimicrobial Agents and Chemotherapy. New Orleans, 1996: abstr. A83. Ivetic Tkalcevic V., Bosnjak B., Hrvacic B. et

al. Anti-inflammatory activity of azithromycin attenuates the effects of lipopolysac- charide administration in mice. Eur. J. Pharmacol. 2006; 539: 131-138. Johnston S.L. Macrolide antibiotics and asthma treatment. J. Allergy Clin. Immunol. 2006; 117: 1233-1236.

Kadota J.-l., Iwashita T., Matsubara Y. et al.

Inhibitory effect of erythromycin on superoxide anion production by human neutrophils primed with granulocyte-colony stimulating factor. Antimicrob. Agents Chemother. 1998; 42: 1866-1867. Karrow N.A., McCay J.A., Brown R.D. et al. Evaluation of the immunomodulatory effects of the macrolide antibiotic, clarithromycin, in female B6C3F1 mice: a 28-day oral gavage study. Drug. Chem. Toxicol. 2001; 24: 19-37. Kawasaki S., Khan A.A., Morikawa K. et

al. Roxithromycin, clarithromycin, and azithromycin attenuate the injurious effects of bioactive phospholipids on human respiratory epithelium in vitro. Inflamation. 1997; 21: 655-665.

Kawasaki S., Khan A.A., Morikawa K. et al.

Modulatory effects of antibiotics on cytokine production by humah monocytes in vitro. Antimicrob. Agents Chemother. 1996; 40: 1366-1370. Kawasaki S., Khan A.A., Slifer T.R. et al. Effect of clarythromycin and azithromycin on production of cytokines by human monocytes. Int. J. Antimicrob. Agents 1999; 11: 121-132. Kawasaki S., Takizawa H., Ohtoshi T. et al.

Roxithromycin inhibits cytokine production by and neutrophil attachment to human bronchial epithelial cells in vitro. Antimicrob. Agents Chemother. 1998; 42:1499-1502. Khair O.A., Devalia J.L., Abdelaziz M.M. et al. Effect of erythromycin on Haemophilus influenzae endotoxin-induced release of IL-6, IL-8 and SiCAMI by cultured human bronchial epithelial cells. Eur. Respir. J. 1995; 8: 1451-1457. Khan A.A., Slifer T.R., Araujo F.G., Remington J.S. Effect of clarythromycin and azithromycin on production of cytokines by human monocytes. Int. J. Antimicrob. Agents 1999; 11: 121-132. Kohyama T., Takizawa Ft., Kawasaki S. et al. Fourteen-member macrolides inhibit interleukin-8 release by human eosinophils from atopic donors. Antimicrob. Agents Chemother. 1999; 43: 907-911. Kozyrskyj A.L., Dahl M.E., Ungar W.J. et al.

Antibiotic treatment of wheezing in children with asthma: what is the practice? Pediatrics 2006; 117: 1104-1110. Labro M.T. Effects of macrolides on host natural defenses. In: Macrolides: chemistry, pharmacology, and clinical uses. Ed. by A.J. Bryskier, J.P. Butzler et al. Paris: Ar- nette-Blackwell, 1993: 389-408. Labro M.T. Effects of macrolides on leukocytes and inflammation. In: Expanding indications for the new macrolides, azalides, and streptogramins. Ed. by S.H. Zinner, L.S. Young et al. New York: Marcel Dekker, 1997: 101-116. Labro M.T. Immunological effects of macrolides. Curr. Opin. Infect. Dis. 1998; 11: 681688. Labro M.T. Interference of Antibacterial Agents with Phagocyte Functions: Immu- nomodulation or Immuno-Fairy Tales? Clin. Microbiol. Rev. 2000; 13: 615-650. Labro M.T., Abdelghaffar H., Babin-Che- vaye C. Interaction of the new ketolide ABT- 773 (cethromycin) with human polymorphonuclear neutrophils and the phagocytic cell line PLB-985 in vitro. Antimicrob. Agents Chemother. 2004; 48: 1096-1104. Langelot M., Cellerin L., Germaud P. Antiinflammatory effects of macrolides: applications in lung disease. Rev. Pneumol. Clin. 2006; 62: 215-222. Lim J.H., Park B.K., Yun H.l. Pharmaco- kinetic/pharmacodynamic modelling of roxithromycin for the inhibitory effect of tumour necrosis factor-alpha and interleukin-6 production in dogs. J. Vet. Med. A Physiol. Pathol. Clin. Med. 2006; 53: 394-398. Me Z., Clark R.F., Brazzale A. et al. Novel erythromycin derivatives with aryl groups tethered to the C-6 position are potent protein synthesis inhibitors and active against multidrug-resistant respiratory pathogens. J. Med. Chem. 2001; 44: 4137-4156. Miossec-Bartoli C., Pilatre L., Peyron P. et al. The new ketolide HMR3647 accumulates in the azurophil granules of human poly- morphonucelar cells. Antimicrob. Agents Chemother. 1999; 43: 2457-2462. Morikawa K., Oseko F., Morikawa S., Iwa- moto K. Immunomodulatory effects of three macrolides, midecamycin acetate, josa- mycin, and clarithromycin, on human T- lymphocyte function in vitro. Antimicrob. Agents Chemother. 1994; 11: 2643-2647. Morikawa K., Watabe H., Araake H., Morikawa S. Modulatory effects of antibiotics on cytokine production by humah monocytes in vitro. Antimicrob. Agents Chemother. 1996; 40: 1366-1370. Munic V., BosnrarM., Kelneric Z. etal. Mac- rolide uptake and release by HL-60 and human polymorphonuclear (PMN) cells. In: Program and abstracts of 6th Int. Conf. Macrolides, Azalides, Streptogramins, Ketolides and Oxazolidinones. 2002: 120. Abstract 4.06

Ouadrhiri Y., Scorneaux B., Sibille Y., Tulkens P.M. Mechanism of intracellular

killing and modulation of abtibiotic susceptibility of Listeria monocytogenes in THP-1 macrophages activated by gamma interferon. Antimicrob. Agents Chemother. 1999; 43: 1242-1251. Parnham M.J. Antibiotics, Inflammation and its resolution: an overview. In: Antibiotics as anti-inflammatory and immunomodulatory agents. Ed. by B.K. Rubin, J. Tamaoki. Basel: Birk Verlag, 2004: 27-48. Parnham M.J. Immunomodulatory effects of antimicrobials in the therapy of respiratory tract infections. Curr. Opin. Infect. Dis. 2005; 18: 125-131. Pascual A., Rodriguez-Bano J., BallestaS. et

al. Azithromycin uptake by tissue cultured epithelial cells. J. Antimicrob. Chemother. 1997; 39: 293-295. Richeldi L., Ferrara G., Fabbri L.M. et al.

Macrolides for chronic asthma. Cochrane Database Syst. Rev. 2005; 4: CD002997. 100.Sacre Hazouri J.A. Macrolides. Antiinflammatory and immunomodulator effects. Indication in respiratory diseases. Rev. Allerg. Mex. 2006; 53: 108-122.

101.Schultz M.J. Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosis. J. Antimicrob. Chemother. 2004; 54: 21-28. VJ2.Shinkai M., Rubin B.K. Macrolides and airway inflammation in children. Paediatr. Respir. Rev. 2005; 6: 227-235.

103.Shimuzu T., Shimuzu S., Hattori R. et al. In vivo and in vitro effects of macrolide antibiotics on mucus secretion in airway epithelian cells. Am. J. Respir. Crit. Care Med. 2003; 168: 581-587.

104.Smith M.E., Ford W.L. The recirculating lymphocyte pool of the rat: a systematic description of the migratory behaviour of recirculating lymphocytes. Immunology 1983; 49: 83-94.

V35.Sugiyama Y., Kitamura S., Kasahara T. Cytokines production from alveolar macrophages of rats fed by long term, low dose erythromycin. In: European Respiratory Society. Annual Congress, 1997. Abstract 0432.

WQ.Vazifeh D., Abdelghaffar H., Labro M.T. Cellular accumulation of the new ketolide RU 64004 by human neutrophils: comparison with that of azithromycin and roxithromycin. Antimicrob. Agents Chemother. 1997; 41: 2099-2107. Vazifeh D., Preira A., Bryskier A., Labro M.T. Interactions between HMR 3647, a new ketolide, and human polymorphonuclear neutrophils. Antimicrob. Agents Chemother. 1998; 42: 1944-1951. Verleden G.M., Vanaudenaerde B.M., Dupont L.J., Van Raemdonck D.E. Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome. Am. J. Respir. Crit. Care Med. 2006; 174: 566-570. Weisblum B. Macrolide resistance. Drug Resist. Update 1998; 1: 29-41. Zeitlinger M., Wagner C.C., Heinisch B. Ketolidesthe modern relatives of macrolides: the pharmacokinetic perspective. Clin. Pharmacokinet. 2009; 48: 23-38. Zuckerman J.M. Macrolides and ketolides: azithromycin, clarithromycin, telithromycin. Infect. Dis. Clin. N. Am. 2004; 18: 621-649.

<< | >>
: .. , .. , .. . 2012. 2012

:

- - - -
- - - - - - - - - - - - - -